Last 12 months
Inside the activity.
1 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 13 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2017 Filed May 19, 2017 20:19 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000100 · wf-form4_149522515839653.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,674.72 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. F2 · balance_after: As of May 18, 2017, Reporting Person owns options to purchase an aggregate of 9,731 shares of Issuer's common stock. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:19 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000099 · wf-form4_149522513865391.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,112.462 F1 · shares: Restricted stock granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan. This restricted stock vests in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:18 UTC |
RAKOWICH WALTER CDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000098 · wf-form4_149522510757913.xml · nonDerivative · entry 1 RAKOWICH WALTER C · CIK 0001202432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,384 F1 · shares: Restricted stock granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan. This restricted stock vests in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:16 UTC |
SHELTON JAMES DDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000097 · wf-form4_149522493366632.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,385.827 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. F2 · balance_after: As of May 18, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:15 UTC |
GILCHRIST RICHARD IDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000096 · wf-form4_149522490811593.xml · nonDerivative · entry 1 GILCHRIST RICHARD I · CIK 0001246346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,932.5815 F1 · shares: Restricted stock granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan. This restricted stock vests in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. F2 · balance_after: As of May 18, 2017, Reporting Person owns options to purchase an aggregate of 8,934 shares of Issuer's common stock. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:15 UTC |
GELLERT JAY MDirector
|
GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000095 · wf-form4_149522489036458.xml · nonDerivative · entry 1 GELLERT JAY M · CIK 0001213928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,741.547 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. F2 · balance_after: As of May 18, 2017, Reporting Person owns options to purchase an aggregate of 29,700 shares of Issuer's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:39 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 345.941 | $65.04 | $22,500.00 |
DisclosureSEC source: 0000740260-17-000080 · wf-form4_149133833970669.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,450.72 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 117.928 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. F3 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 9,731 shares of Issuer's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:38 UTC |
GELLERT JAY MDirector
|
GrantCommon Stock | 442.036 | $65.04 | $28,750.02 |
DisclosureSEC source: 0000740260-17-000079 · wf-form4_149133831912464.xml · nonDerivative · entry 1 GELLERT JAY M · CIK 0001213928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,517.547 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 398.009 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. F3 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 29,700 shares of Issuer's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:38 UTC |
RUFRANO GLENN JDirector
|
GrantCommon Stock | 422.817 | $65.04 | $27,500.02 |
DisclosureSEC source: 0000740260-17-000078 · wf-form4_149133830002745.xml · nonDerivative · entry 1 RUFRANO GLENN J · CIK 0001167958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,098.337 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 178.416 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. F3 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 15,265 shares of Issuer's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:38 UTC |
Reed Robert D.Director
|
GrantCommon Stock | 442.036 | $65.04 | $28,750.02 |
DisclosureSEC source: 0000740260-17-000077 · wf-form4_149133827712331.xml · nonDerivative · entry 1 Reed Robert D. · CIK 0001429381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,284.473 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:37 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 422.817 | $65.04 | $27,500.02 |
DisclosureSEC source: 0000740260-17-000076 · wf-form4_149133824883050.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,888.462 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 15.375 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:37 UTC |
SHELTON JAMES DDirector
|
GrantCommon Stock | 297.894 | $65.04 | $19,375.03 |
DisclosureSEC source: 0000740260-17-000075 · wf-form4_149133822910271.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,161.827 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 94.556 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. F3 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:58 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,295 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0000740260-17-000068 · wf-form4_148943869551649.xml · derivative · entry 3 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,581 Underlying: Common Stock · 10,295 shares Expires 2027-03-10 F3 · shares: Stock options granted by Issuer pursuant to the Plan. F4 · derivative.exercise_date: These options vest in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:58 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
GrantCommon Stock | 2,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000068 · wf-form4_148943869551649.xml · nonDerivative · entry 2 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,979.578 F2 · shares: Restricted stock granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). This restricted stock vests in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 20:58 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,020 | $60.07 | $61,271.40 |
DisclosureSEC source: 0000740260-17-000068 · wf-form4_148943869551649.xml · nonDerivative · entry 1 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,923.578 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on March 9, 2012 under the Ventas, Inc. 2006 Incentive Plan. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 20:58 UTC |
Cobb John D.EVP, Chief Investment Off.
|
Tax withholdingCommon Stock | 6,860 | $60.07 | $412,080.20 |
DisclosureSEC source: 0000740260-17-000067 · wf-form4_148943867180410.xml · nonDerivative · entry 1 Cobb John D. · CIK 0001505545 · EVP, Chief Investment Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,305 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on March 9, 2012 under the Ventas, Inc. 2006 Incentive Plan. F2 · balance_after: As of March 9, 2017, Reporting Person owns options to purchase an aggregate of 430,918 shares of Issuer's common stock. Read SEC document |
| March 07, 2017 Filed Mar 7, 2017 22:01 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 84 | $62.67 | $5,264.28 |
DisclosureSEC source: 0000740260-17-000064 · wf-form4_148892405661401.xml · nonDerivative · entry 3 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,943.578 F3 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on March 7, 2014 under the Plan. F4 · balance_after: As of March 7, 2017, Reporting Person owns options to purchase an aggregate of 12,286 shares of Issuer's common stock. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 22:01 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 102 | $62.71 | $6,396.42 |
DisclosureSEC source: 0000740260-17-000064 · wf-form4_148892405661401.xml · nonDerivative · entry 2 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,027.578 F2 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on March 6, 2015 under the Plan. Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 22:01 UTC |
Liebbe Gregory RSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 151 | $63.66 | $9,612.66 |
DisclosureSEC source: 0000740260-17-000064 · wf-form4_148892405661401.xml · nonDerivative · entry 1 Liebbe Gregory R · CIK 0001655010 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,129.578 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on March 4, 2016 under the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Read SEC document |
| February 28, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,762 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · derivative · entry 10 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,762 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person that became fully vested on December 31, 2011. Read SEC document |
| February 28, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
SaleCommon Stock | 3,762 | $65.60 | $246,787.20 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 6 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,022 Read SEC document |
| February 28, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionCommon Stock | 3,762 | $40.91 | $153,903.42 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 5 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 71,211 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · derivative · entry 12 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,518 Underlying: Common Stock · 71,211 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,058 | $0.00 Strike: $55.50 | $0.00 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · derivative · entry 11 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,729 Underlying: Common Stock · 32,058 shares Expires 2023-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,631 | $0.00 Strike: $46.88 | $0.00 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · derivative · entry 10 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,787 Underlying: Common Stock · 29,631 shares Expires 2022-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,459 | $0.00 Strike: $45.03 | $0.00 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · derivative · entry 9 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,418 Underlying: Common Stock · 9,459 shares Expires 2021-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person which vested in three equal annual installments beginning on the date of grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
SaleCommon Stock | 71,211 | $65.02 | $4,630,331.49 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 8 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,572.246 F1 · shares: On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). F2 · balance_after: Includes 34.203 shares acquired between January 18, 2017 and February 28, 2017 under the Ventas Employee and Director Stock Purchase Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionCommon Stock | 71,211 | $51.85 | $3,692,290.35 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 7 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,749.043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
SaleCommon Stock | 32,058 | $65.02 | $2,084,497.72 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 6 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,538.043 F1 · shares: On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionCommon Stock | 32,058 | $55.50 | $1,779,219.00 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 5 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,596.043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
SaleCommon Stock | 29,631 | $65.02 | $1,926,687.62 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 4 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,538.043 F1 · shares: On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionCommon Stock | 29,631 | $46.88 | $1,389,101.28 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 3 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,169.043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
SaleCommon Stock | 9,459 | $65.02 | $615,049.72 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 2 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,538.043 F1 · shares: On February 28, 2017, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.00 to $65.185, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Exercise / conversionCommon Stock | 9,459 | $45.03 | $425,938.77 |
DisclosureSEC source: 0000740260-17-000062 · wf-form4_148849125168529.xml · nonDerivative · entry 1 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,997.043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · derivative · entry 9 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 10,000 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person that became fully vested on December 31, 2011. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
SaleCommon Stock | 10,000 | $65.45 | $654,479.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 4 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,022 F2 · shares: The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.30 to $65.70, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionCommon Stock | 10,000 | $40.91 | $409,100.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 3 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · derivative · entry 8 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,762 Underlying: Common Stock · 5,000 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person that became fully vested on December 31, 2011. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
SaleCommon Stock | 5,000 | $62.90 | $314,500.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 2 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,022 F1 · shares: On February 24, 2017, the Reporting Person transmitted to the Securities and Exchange Commission a Form 144 covering the sale of the Issuer's common stock reported in Table I. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:25 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionCommon Stock | 5,000 | $40.91 | $204,550.00 |
DisclosureSEC source: 0000740260-17-000060 · wf-form4_148831709233823.xml · nonDerivative · entry 1 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:09 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $40.91 | $0.00 |
DisclosureSEC source: 0000740260-17-000058 · wf-form4_148788777045170.xml · derivative · entry 4 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,762 Underlying: Common Stock · 5,000 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were part of a previously reported grant by the Issuer to the Reporting Person that became fully vested on December 31, 2011. F3 · balance_after: Represents total number of unexercised stock options held by the Reporting Person as of February 21, 2017. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:09 UTC |
PASQUALE DOUGLAS MDirector
|
SaleCommon Stock | 5,000 | $62.90 | $314,500.00 |
DisclosureSEC source: 0000740260-17-000058 · wf-form4_148788777045170.xml · nonDerivative · entry 2 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,022 F1 · shares: On February 22, 2017, the Reporting Person transmitted to the Securities and Exchange Commission a Form 144 covering the sale of the Issuer's common stock reported in Table I. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:09 UTC |
PASQUALE DOUGLAS MDirector
|
Exercise / conversionCommon Stock | 5,000 | $40.91 | $204,550.00 |
DisclosureSEC source: 0000740260-17-000058 · wf-form4_148788777045170.xml · nonDerivative · entry 1 PASQUALE DOUGLAS M · CIK 0001070021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2017 Filed Jan 30, 2017 21:39 UTC |
Probst Robert FEVP and CFO
|
Tax withholdingCommon Stock | 2,241 | $61.08 | $136,880.28 |
DisclosureSEC source: 0000740260-17-000050 · wf-form4_148581237323396.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,343 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Ventas, Inc. 2012 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person owns options to purchase an aggregate of 346,140 shares of Issuer's common stock. Read SEC document |
| January 27, 2017 Filed Jan 30, 2017 21:39 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Tax withholdingCommon Stock | 8,265 | $61.08 | $504,826.20 |
DisclosureSEC source: 0000740260-17-000049 · wf-form4_148581235801249.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,835 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Ventas, Inc. 2012 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person owns options to purchase an aggregate of 2,790,859 shares of Issuer's common stock. Read SEC document |
| January 27, 2017 Filed Jan 30, 2017 21:39 UTC |
Cobb John D.EVP, Chief Investment Off.
|
Tax withholdingCommon Stock | 2,068 | $61.08 | $126,313.44 |
DisclosureSEC source: 0000740260-17-000048 · wf-form4_148581233931360.xml · nonDerivative · entry 1 Cobb John D. · CIK 0001505545 · EVP, Chief Investment Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,165 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Plan. F2 · balance_after: As of January 27, 2017, Reporting Person owns options to purchase an aggregate of 430,918 shares of Issuer's common stock. Read SEC document |
| January 27, 2017 Filed Jan 30, 2017 21:38 UTC |
RINEY T RICHARDEVP, Chief Admin. Off., GC
|
Tax withholdingCommon Stock | 2,155 | $61.08 | $131,627.40 |
DisclosureSEC source: 0000740260-17-000047 · wf-form4_148581232256678.xml · nonDerivative · entry 1 RINEY T RICHARD · CIK 0001215185 · EVP, Chief Admin. Off., GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,579 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Ventas, Inc. 2012 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person owns options to purchase an aggregate of 367,345 shares of Issuer's common stock. Read SEC document |
| January 27, 2017 Filed Jan 30, 2017 21:38 UTC |
Lillibridge Todd W.EVP, Medical Prop. Operations
|
Tax withholdingCommon Stock | 1,620 | $61.08 | $98,949.60 |
DisclosureSEC source: 0000740260-17-000046 · wf-form4_148581230385946.xml · nonDerivative · entry 1 Lillibridge Todd W. · CIK 0001494933 · EVP, Medical Prop. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,538.043 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Ventas, Inc. 2012 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person owns options to purchase an aggregate of 464,877 shares of Issuer's common stock. Read SEC document |
| January 21, 2017 Filed Jan 24, 2017 21:33 UTC |
Cobb John D.EVP, Chief Investment Off.
|
Tax withholdingCommon Stock | 1,690 | $61.90 | $104,611.00 |
DisclosureSEC source: 0000740260-17-000039 · wf-form4_148529361048197.xml · nonDerivative · entry 2 Cobb John D. · CIK 0001505545 · EVP, Chief Investment Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,233 F2 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 21, 2015 under the Plan. F3 · balance_after: As of January 21, 2017, Reporting Person owns options to purchase an aggregate of 430,918 shares of Issuer's common stock. Read SEC document |
| January 21, 2017 Filed Jan 24, 2017 21:33 UTC |
Cobb John D.EVP, Chief Investment Off.
|
Tax withholdingCommon Stock | 1,426 | $61.90 | $88,269.40 |
DisclosureSEC source: 0000740260-17-000039 · wf-form4_148529361048197.xml · nonDerivative · entry 1 Cobb John D. · CIK 0001505545 · EVP, Chief Investment Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,923 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 21, 2015 under the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.